Hepatocyte nuclear factor-1beta (HNF-1beta) is a Pit-1, Oct-1/2, Unc-86 (POU) homeodomain-containing
transcription factor expressed in the kidney, liver, pancreas, and other epithelial organs. Mutations of
HNF-1beta cause
maturity-onset diabetes of the young, type 5 (MODY5), which is characterized by early-onset
diabetes mellitus and congenital malformations of the kidney, pancreas, and genital tract. Knockout of
HNF-1beta in the mouse kidney results in
cyst formation. However, the signaling pathways and transcriptional programs controlled by
HNF-1beta are poorly understood. Using genome-wide
chromatin immunoprecipitation and
DNA microarray (ChIP-chip) and microarray analysis of
mRNA expression, we identified SOCS3 (suppressor of
cytokine signaling-3) as a previously unrecognized target gene of
HNF-1beta in the kidney.
HNF-1beta binds to the SOCS3 promoter and represses SOCS3 transcription. The expression of SOCS3 is increased in
HNF-1beta knockout mice and in renal epithelial cells expressing dominant-negative mutant
HNF-1beta. Increased levels of SOCS-3 inhibit HGF-induced tubulogenesis by decreasing phosphorylation of Erk and STAT-3. Conversely, knockdown of SOCS-3 in renal epithelial cells expressing dominant-negative mutant
HNF-1beta rescues the defect in HGF-induced tubulogenesis by restoring phosphorylation of Erk and STAT-3. Thus,
HNF-1beta regulates tubulogenesis by controlling the levels of SOCS-3 expression. Manipulating the levels of SOCS-3 may be a useful therapeutic approach for human diseases induced by
HNF-1beta mutations.